Unlike most female mammals whose vaginal entrance opens before or during puberty and remains that way for the rest of their lives, this rodent’s vaginal entrance remains sealed into adulthood and has the ability to open or close back up multiple times during a lifetime.
Edward Dean Wolf, a pioneer in nanofabrication who joined Cornell in 1978 as the first director of what would become the Cornell Nanoscale Science and Technology Facility, died March 11 in Ithaca. He was 87.
Carlos Alvarado Quesada, former president of Costa Rica, spoke at the Bartels World Affairs Lecture on how he dealt with challenges related to democracy and the environment during his presidency from 2018 to 2022.
Multiple types of beta cells produce insulin in the pancreas, helping to balance blood sugar levels. Losing a particularly productive type of beta cell may contribute to the development of diabetes, according to a new study by Weill Cornell Medicine investigators.
In flood-prone New York, non-white homeowners are more likely to take active measures – like protecting a furnace or installing a sump pump – to prepare for deluge, says Cornell research.
The Cornell Institute for Digital Agriculture Hackathon, an all-weekend event, drew 150 undergraduate and graduate students from most of Cornell’s schools and colleges to the College of Veterinary Medicine.
The Inclusive Wellness Series, sponsored by Cornell’s Department of Inclusion and Belonging in partnership with the Graduate School Office of Inclusion and Student Engagement and the Office of Faculty Development and Diversity, hosted a well-attended public talk with Dr. Leah Hollis on March 10 about her research on workplace bullying in higher education.
Teams from eLab, Cornell’s student accelerator, and Cornell Tech’s Runway Startups program will pitch their ideas to the West Coast Cornell community at Cornell Silicon Valley Presents: Student Startup Showcase March 30 at the Autodesk Gallery in San Francisco.
Obesity may spur DNA damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to breast cancer development in this already high-risk group, according to new multi-institutional translational research led by Weill Cornell Medicine scientists.
